NATURALLY SPLENDID ENTERPRISES LTD. (“Naturally Splendid” or “NSE”) (TSXV:NSP)(OTC:NSPDF)(FRANKFURT:50N) is pleased to announce that Sipp Industries Inc. (“SIPP”) has finalized an agreement with Sparta Distributing for distribution of Major Hemp HIPA in the state of Missouri. Major Hemp H-IPA utilizes Naturally Splendid’s propriety microencapsulated hemp oil, HempOmega(TM), in the formula of the beer creating unique, competitive advantages.
Naturally Splendid President Mr. Craig Goodwin states,” We are excited to provide a further update on Major Hemp HIPA penetrating the US craft beer market segment and extending distribution even further. This is a significant achievement for our HempOmega(TM) as we continue to expand the applications of our proprietary technology. HempOmega(TM) is continuing to prove it’s value by enhancing numerous varied product lines including practitioner products, sports nutrition and skincare. We would like to congratulate SIPP for their continued success in the US and look forward to supporting their aggressive growth strategy.”
Missouri is a state with a long tradition of possessing a great appreciation for craft beer. It is the home of Anheuser-Busch, who created and then developed Budweiser into the first national beer brand in America. Whenever a novel craft brew enters the confines of Missouri, its citizens display a tendency to gravitate towards it.
Sparta serves the largest population centers in Missouri, including the Kansas City metropolitan area, St. Louis and Springfield, as well as Columbia, where the University of Missouri is located. Following the successful sampling of Major Hemp HIPA throughout Missouri, Sparta Distributing and Sipp Industries will now partner to distribute this premium craft hemp-infused beer in its second midwestern state.
Major Hemp HIPA continues to receive excellent reviews on taste and uniqueness, which has resulted in consistent reorders. Though the federal government shutdown caused a delay in processing times, the Company has now received both formula and label approval from the Alcohol and Tobacco Tax and Trade Bureau (TTB) for Major Hemp HIPA.
President Ted Jorgensen of wholly-owned subsidiary, Major Hemp, commented, “We are thrilled to finalize terms with Sparta Distributing for the distribution of our hemp beer in Missouri. With the proper TTB approvals we can now significantly increase our distribution efforts, as these approvals permit the interstate shipping of HIPA, which is a very important milestone for us. We are currently speaking with some great potential brewery and distribution partners that would allow for the rapid dissemination of Major Hemp HIPA and Major Hemp Brown Ale through a wide swath of the United States.
About Sipp Industries, Inc.
For more information, please visit www. www.sippindustries.com
About Naturally Splendid Enterprises Ltd.
Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp cannabinoid compounds in a broad spectrum of applications.
For more information e-mail firstname.lastname@example.org or call Investor Relations at
On Behalf of the Board of Directors
Mr. Douglas Mason
Naturally Splendid Enterprises Ltd.
(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)
#108-19100 Airport Way
Pitt Meadows, BC, V3Y 0E2
Office: (604) 465-0548
Fax: (604) 465-1128
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications, including its application to obtain a Standard Processing License, may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ retail stores, today announced that its executive team will participate in the following conference in March 2021:
Needham 2 nd Annual Virtual Cannabis Conference, March 3, 2021: Management will participate in one-on-one meetings.
Meanwhile, two longstanding cannabis partners ended their relationship.
Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development
Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.
The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.
With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.